Folger Nolan Fleming Douglas Capital Management Inc. Sells 187 Shares of Danaher Co. (NYSE:DHR)

Folger Nolan Fleming Douglas Capital Management Inc. reduced its holdings in shares of Danaher Co. (NYSE:DHR) by 4.6% in the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 3,850 shares of the conglomerate’s stock after selling 187 shares during the quarter. Folger Nolan Fleming Douglas Capital Management Inc.’s holdings in Danaher were worth $789,000 at the end of the most recent reporting period.

Several other hedge funds also recently made changes to their positions in DHR. Heck Capital Advisors LLC bought a new position in shares of Danaher during the 4th quarter worth approximately $27,000. Strategic Financial Concepts LLC bought a new position in Danaher during the fourth quarter worth $31,000. Kentucky Trust Co bought a new position in Danaher during the fourth quarter worth $34,000. Rialto Wealth Management LLC bought a new position in Danaher during the fourth quarter worth $34,000. Finally, Hurley Capital LLC bought a new position in Danaher during the fourth quarter worth $34,000. 79.05% of the stock is owned by institutional investors.

Insider Transactions at Danaher

In other news, EVP Christopher Paul Riley sold 15,805 shares of the stock in a transaction on Wednesday, April 30th. The stock was sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the completion of the transaction, the executive vice president now owns 15,179 shares in the company, valued at approximately $3,005,442. This represents a 51.01% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Chairman Steven M. Rales sold 1,250,000 shares of the stock in a transaction on Monday, May 12th. The stock was sold at an average price of $196.74, for a total value of $245,925,000.00. Following the transaction, the chairman now owns 3,105,808 shares of the company’s stock, valued at $611,036,665.92. The trade was a 28.70% decrease in their position. The disclosure for this sale can be found here. 11.10% of the stock is owned by insiders.

Danaher Price Performance

Shares of DHR opened at $204.85 on Friday. Danaher Co. has a 52-week low of $171.00 and a 52-week high of $281.70. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. The business’s 50 day moving average price is $192.27 and its two-hundred day moving average price is $211.44. The firm has a market cap of $146.60 billion, a PE ratio of 38.80, a price-to-earnings-growth ratio of 2.66 and a beta of 0.77.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.62 by $0.26. Danaher had a return on equity of 10.82% and a net margin of 16.33%. The firm had revenue of $5.74 billion for the quarter, compared to analyst estimates of $5.58 billion. On average, equities analysts anticipate that Danaher Co. will post 7.63 EPS for the current year.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be given a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.62%. Danaher’s payout ratio is 24.85%.

Wall Street Analysts Forecast Growth

DHR has been the subject of a number of research analyst reports. Royal Bank of Canada reaffirmed an “outperform” rating and set a $250.00 price objective on shares of Danaher in a research report on Wednesday, April 23rd. Evercore ISI dropped their target price on Danaher from $240.00 to $230.00 and set an “outperform” rating for the company in a report on Tuesday, April 22nd. Citigroup reaffirmed a “buy” rating on shares of Danaher in a research note on Monday, April 7th. Argus dropped their price target on Danaher from $260.00 to $240.00 in a research note on Wednesday, April 23rd. Finally, Wells Fargo & Company dropped their price target on Danaher from $240.00 to $210.00 and set an “equal weight” rating for the company in a research note on Wednesday, April 23rd. Five analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $248.17.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.